Publications by authors named "Yolanda Ber"

Claim this Profile
F
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, Ruth de Francisco, Francisco Javier García-Alonso, Yolanda Ber, Fernando Bermejo, Pau Gilabert, Javier P Gisbert

Aliment Pharmacol Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.
Míriam Mañosa, Margalida Calafat, Elena Ricart, Pilar Nos, Eva Iglesias, Javier P Gisbert, Fernando Bermejo, Yolanda Ber, Pau Gilabert

United European Gastroenterol J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkers.
Montse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, Irene Soleto, Macarena Orejudo, Fernando Bermejo, Yolanda Ber, Javier P Gisbert

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics.
Macarena Orejudo, Manuel J Gómez, Sabino Riestra, Montserrat Rivero, Ana Gutiérrez, Fernando Bermejo, Yolanda Ber, Javier P Gisbert

Front Cell Infect Microbiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Fernando Bermejo, Yolanda Ber, Javier P Gisbert

Pharmaceutics· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.
Laila Aldars-García, Rubén Gil-Redondo, Nieves Embade, Sabino Riestra, Montserrat Rivero, Fernando Bermejo, Yolanda Ber, David Bernardo, Javier P Gisbert

Inflamm Bowel Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of Paediatric to Adult Transition Programme in Inflammatory Bowel Disease: The BUTTERFLY Study of GETECCU and SEGHNP.
Cristina Rubín de Célix, Javier Martín-de-Carpi, Gemma Pujol-Muncunill, Laura María Palomino, Marta Velasco Rodríguez-Belvís, José Ramón Alberto Alonso, Yolanda Ber, Javier P Gisbert

J Clin Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Presentation, Management, and Evolution of Lymphomas in Patients with Inflammatory Bowel Disease: An ENEIDA Registry Study.
Ivan Guerra, Luis Bujanda, Miriam Mañosa, Isabel Pérez-Martínez, María José Casanova, Lorena Bernal, Yolanda Ber, Pau Gilabert, Javier P Gisbert, Fernando Bermejo

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. 2021, , 2885.
María Chaparro, Ana Garre, Andrea Núñez Ortiz, María Teresa Diz-Lois Palomares, Cristina Rodríguez, Fernando Bermejo, Yolanda Ber, Alberto Mir, Javier P Gisbert

J Clin Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice.
Fernando Gomollón, Daniel Seoane-Mato, Miguel A Montoro, Xavier Juanola, Elisa Trujillo-Martin, Yolanda Ber

Dig Liver Dis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract.
Yolanda Ber, Santiago García-Lopez, Carla J Gargallo-Puyuelo, Fernando Gomollón

Nutrients· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
María Chaparro, Ana Garre, Andrea Núñez Ortiz, María Teresa Diz-Lois Palomares, Cristina Rodríguez, Fernando Bermejo, Yolanda Ber, Alberto Mir, Javier P Gisbert

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Xavier Andújar, Carme Loras, Begoña González, Milena Socarras, Vicente Sanchiz, Yolanda Ber

Surg Endosc· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.
Xavier Andújar, Carme Loras, Begoña González, Milena Socarras, Vicente Sanchiz, Yolanda Ber

Surg Endosc· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Ivan Guerra, Luis Bujanda, Jesús Castro, Olga Merino, Joan Tosca, Yolanda Ber, Albert Villoria, Fernando Bermejo, Javier P Gisbert

J Crohns Colitis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.
Marisa Iborra, Javier Pérez-Gisbert, Marta Maia Bosca-Watts, Alicia López-García, Valle García-Sánchez, Yolanda Ber, Albert Villoria

J Gastroenterol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.
Marisa Iborra, Javier P Gisbert, Marta Maia Bosca-Watts, Alicia López-García, Valle García-Sánchez, Yolanda Ber, Albert Villoria

J Gastroenterol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.
María Del Carmen R-Grau, María Chaparro, Francisco Mesonero, Manuel Barreiro-de Acosta, Luisa Castro, Fernando Bermejo, Yolanda Ber, Javier P Gisbert

Dig Liver Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Iván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, Alicia Algaba, David Monfort, Yolanda Ber, Fernando Bermejo, Javier P Gisbert

Inflamm Bowel Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of liver transplantation using donors older than 60 years of age.
Maria Trinidad Serrano, Agustín Garcia-Gil, Juan Arenas, Yolanda Ber, Luis Cortes

Clin Transplant· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis